FinData: Share Price for NASDAQ, BIIB

Saturday, 20 April 2024

Biogen Idec Inc

NASDAQ : BIIB 264.63 14 Oct 22 00:00	Change: 5.31	Open: 270.65	High: 272.62	Ask: 51.95	Volume: 1,478,800
NASDAQ : BIIB 264.63 14 Oct 22 00:00	Change(%): 1.97	Prev: 269.94	Low: 264.03	Bid: 51.65	Avg vol: 0

Latest News

Biogen's Bargain Price May Spur a 14% Stock Gain
07:33 | 14/3/18

Investopedia (blog)
(Note: The author of this fundamental analysis is a financial writer and portfolio manager. He and his clients own shares of CELG. more»
Buy or Sell? Average Brokerage Ratings on Biogen Inc. (BIIB), La Quinta ...
05:30 | 14/3/18

StockNewsJournal
Investors who are keeping close eye on the stock of Biogen Inc. (NASDAQ:BIIB) established that the company was able to keep return on investment at 19.33 in the trailing twelve month while Reuters data showed that industry's average stands at 14.08 and ... more»
Biogen to Buy Mid-Stage Neuropsychiatry Asset From Pfizer
03:03 | 14/3/18

Nasdaq
Biogen Inc. BIIB has agreed to acquire a phase IIb ready candidate, PF-04958242, which is being developed for cognitive impairment associated with schizophrenia (CIAS) from pharma giant Pfizer, Inc. PFE . more»
Biogen to buy schizophrenia drug from Pfizer for up to US$590mln
01:22 | 13/3/18

Proactive Investors UK
Biogen Inc (NASDAQ:BIIB) has agreed to buy a Phase IIb trial-ready schizophrenia treatment from fellow pharma giant Pfizer Inc (NYSE:PFE), in a deal worth up to US$590mln. more»
Biogen Inc (NASDAQ:BIIB): Are Forecast Margins sustainable?
05:30 | 10/3/18

Simply Wall St
Biogen's encouraging earnings sentiment drives analysts to forecast substantial growth of 84.82% over the next year, but let's stop and think through this projection. more»

There are currently no comments on this topic.
Be the first person to Add a Comment...

Add a Comment

You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW

Global Indices